Feraccru is indicated for the treatment of iron deficiency in adults and adolescents aged 12 years and older.
ACCRUFER — SHIELD TX, approved 2025-12-19 (NDA212320).
982 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.